Four neonates with a positive phenylalanine screening test (Phe concentrati
ons between 258 and 1250 mu mol/L) were investigated further to differentia
te between phenylalanine hydroxylase (PAH) deficiency and variant hyperphen
ylalaninaemia (HPA) forms. In patients 1 and 2 a tetrahydrobiopterin (BH4)
load caused a significant decrease of the plasma Phe levels. A combined phe
nylalanine/BH4 loading test was performed in patients 2, 3 and 4. In the la
tter two patients, plasma Phe concentrations completely normalized within 8
h after the BH4 load (20 mg/kg). Basal urinary pterins were normal in all
four patients. The activity of dihydropteridine reductase (DHPR) was normal
in patients 1, 2 and 3 and 50% of control values in patient 4 (not in the
range of DHPR-deficient patients). In patient 3 a subsequent phenylalanine
loading test with concomitant analysis of plasma biopterins revealed a norm
al increase of biopterin, excluding a BH4 biosynthesis defect. Pterins and
neurotransmitter metabolites in CSF of patients 1, 3 and 4 were normal. DNA
mutations detected in the PAH gene of patients 1-4 were A313T, and L367fsi
nsC; V190A and R243X; A300S and A403V; R241C and A403V. The results are sug
gestive for mutant PAH enzymes with decreased affinity for the cofactor BH4
.